Kiromic Biopharma, Inc. Debt Conversion, Converted Instrument, Amount
Kiromic Biopharma, Inc. reported Debt Conversion, Converted Instrument, Amount of $8.00 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2024-05-10
- Kiromic Biopharma, Inc. debt conversion, converted instrument, amount for the quarter ending 2024-03-31 was $8.00M.
- Kiromic Biopharma, Inc. debt conversion, converted instrument, amount for the quarter ending 2023-12-31 was $0.00.
- Kiromic Biopharma, Inc. debt conversion, converted instrument, amount for the quarter ending 2023-09-30 was $6.00M.
- Kiromic Biopharma, Inc. debt conversion, converted instrument, amount for the quarter ending 2019-12-31 was $0.00.
- Kiromic Biopharma, Inc. debt conversion, converted instrument, amount for fiscal 2023 was $14.00M.
- Kiromic Biopharma, Inc. debt conversion, converted instrument, amount for fiscal 2019 was $407.30K.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2024-03-31 | $8.00M 10-Q · filed 2024-05-10 | $8.00M derived: sum of 2 quarters · filed 2024-05-10 | $14.00M derived: sum of 3 quarters · filed 2024-05-10 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $6.00M derived: sum of 2 quarters · filed 2024-03-19 | $14.00M 10-K · filed 2024-03-19 | |
| 2023-09-30 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $14.00M 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $8.00M 10-Q · filed 2023-08-14 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $407.30K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $407.30K 10-Q · filed 2020-11-30 |